The purpose of this study is to determine if the study drug called ALZ-801 is safe, if it is well tolerated, and if it is effective in treating AD. It is a twice a day oral medication that is taken with meals.

General Eligibility

  • Diagnosis of MCI due to AD or mild AD
  • 50-80 years old in good health
  • Has a trial partner to come to visits

Primary Investigator: Malgorzata Franczak, MD

Status: Currently Enrolling

Sub Category